Related Experiment Video
Updated: Jul 12, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
[Immunosuppressive acid protein in lung tuberculosis]
1Landmark Clinic, Yokohama, Japan.
Immunosuppressive acid protein (IAP) is elevated in active lung tuberculosis cases. This marker shows promise for assessing disease activity, outperforming the erythrocyte sedimentation rate (ESR).
Area of Science:
- Biochemistry
- Immunology
- Pulmonology
Context:
- Tuberculosis diagnosis and monitoring remain critical global health challenges.
- Accurate assessment of disease activity is essential for effective treatment of lung tuberculosis.
- Existing biomarkers like ESR have limitations in sensitivity and specificity.
Purpose:
- To investigate the potential of Immunosuppressive acid protein (IAP) as a biomarker for active lung tuberculosis.
- To compare the efficacy of IAP with the erythrocyte sedimentation rate (ESR) in evaluating disease activity.
- To assess the correlation between IAP levels and clinical improvement in tuberculosis patients.
Summary:
- Immunosuppressive acid protein (IAP) levels were significantly elevated in patients with active lung tuberculosis compared to those with old tuberculosis and healthy controls.
- IAP levels decreased progressively with clinical improvement, indicating its dynamic response to treatment.
- IAP demonstrated higher sensitivity than ESR in reflecting disease activity, suggesting its superiority as a diagnostic marker.
Impact:
- IAP emerges as a potentially valuable and sensitive biomarker for monitoring the clinical activity of lung tuberculosis.
- This finding could lead to improved diagnostic and prognostic tools for tuberculosis management.
- Further research validating IAP could enhance patient care and treatment strategies for tuberculosis.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis